1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base and Forecast Years Timeline
1.8. Key Benefits for the Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Research Process
3. EXECUTIVE SUMMARY
3.1. Key Findings
3.2. Analyst View
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
4.5. Analyst View
5. GLOBAL IN VITRO FERTILIZATION (IVF) MARKET BY CYCLE TYPE
5.1. Introduction
5.2. Fresh IVF Cycle
5.2.1. Market Trends and Opportunities
5.2.2. Growth Prospects
5.2.3. Geographic Lucrativeness
5.3. Thawed IVF Cycle
5.3.1. Market Trends and Opportunities
5.3.2. Growth Prospects
5.3.3. Geographic Lucrativeness
5.4. Donor Egg IVF Cycle
5.4.1. Market Trends and Opportunities
5.4.2. Growth Prospects
5.4.3. Geographic Lucrativeness
6. GLOBAL IN VITRO FERTILIZATION (IVF) MARKET BY END-USER
6.1. Introduction
6.2. Fertility Clinics
6.2.1. Market Trends and Opportunities
6.2.2. Growth Prospects
6.2.3. Geographic Lucrativeness
6.3. Hospitals and Research Centers
6.3.1. Market Trends and Opportunities
6.3.2. Growth Prospects
6.3.3. Geographic Lucrativeness
7. GLOBAL IN VITRO FERTILIZATION (IVF) MARKET BY GEOGRAPHY
7.1. Introduction
7.2. North America
7.2.1. By Cycle Type
7.2.2. By End-User
7.2.3. By Country
7.2.3.1. USA
7.2.3.1.1. Market Trends and Opportunities
7.2.3.1.2. Growth Prospects
7.2.3.2. Canada
7.2.3.2.1. Market Trends and Opportunities
7.2.3.2.2. Growth Prospects
7.2.3.3. Mexico
7.2.3.3.1. Market Trends and Opportunities
7.2.3.3.2. Growth Prospects
7.3. South America
7.3.1. By Cycle Type
7.3.2. By End-User
7.3.3. By Country
7.3.3.1. Brazil
7.3.3.1.1. Market Trends and Opportunities
7.3.3.1.2. Growth Prospects
7.3.3.2. Argentina
7.3.3.2.1. Market Trends and Opportunities
7.3.3.2.2. Growth Prospects
7.3.3.3. Others
7.3.3.3.1. Market Trends and Opportunities
7.3.3.3.2. Growth Prospects
7.4. Europe
7.4.1. By Cycle Type
7.4.2. By End-User
7.4.3. By Country
7.4.3.1. Germany
7.4.3.1.1. Market Trends and Opportunities
7.4.3.1.2. Growth Prospects
7.4.3.2. France
7.4.3.2.1. Market Trends and Opportunities
7.4.3.2.2. Growth Prospects
7.4.3.3. United Kingdom
7.4.3.3.1. Market Trends and Opportunities
7.4.3.3.2. Growth Prospects
7.4.3.4. Italy
7.4.3.4.1. Market Trends and Opportunities
7.4.3.4.2. Growth Prospects
7.4.3.5. Others
7.4.3.5.1. Market Trends and Opportunities
7.4.3.5.2. Growth Prospects
7.5. Middle East and Africa
7.5.1. By Cycle Type
7.5.2. By End-User
7.5.3. By Country
7.5.3.1. Saudi Arabia
7.5.3.1.1. Market Trends and Opportunities
7.5.3.1.2. Growth Prospects
7.5.3.2. UAE
7.5.3.2.1. Market Trends and Opportunities
7.5.3.2.2. Growth Prospects
7.5.3.3. Others
7.5.3.3.1. Market Trends and Opportunities
7.5.3.3.2. Growth Prospects
7.6. Asia Pacific
7.6.1. By Cycle Type
7.6.2. By End-User
7.6.3. By Country
7.6.3.1. India
7.6.3.1.1. Market Trends and Opportunities
7.6.3.1.2. Growth Prospects
7.6.3.2. China
7.6.3.2.1. Market Trends and Opportunities
7.6.3.2.2. Growth Prospects
7.6.3.3. Japan
7.6.3.3.1. Market Trends and Opportunities
7.6.3.3.2. Growth Prospects
7.6.3.4. South Korea
7.6.3.4.1. Market Trends and Opportunities
7.6.3.4.2. Growth Prospects
7.6.3.5. Taiwan
7.6.3.5.1. Market Trends and Opportunities
7.6.3.5.2. Growth Prospects
7.6.3.6. Thailand
7.6.3.6.1. Market Trends and Opportunities
7.6.3.6.2. Growth Prospects
7.6.3.7. Indonesia
7.6.3.7.1. Market Trends and Opportunities
7.6.3.7.2. Growth Prospects
7.6.3.8. Others
7.6.3.8.1. Market Trends and Opportunities
7.6.3.8.2. Growth Prospects
8. COMPETITIVE ENVIRONMENT AND ANALYSIS
8.1. Major Players and Strategy Analysis
8.2. Market Share Analysis
8.3. Mergers, Acquisitions, Agreements, and Collaborations
8.4. Competitive Dashboard
9. COMPANY PROFILES
9.1. Cooper Surgical (Cook Medicals)
9.2. Vitrolife AB
9.3. Thermo Fisher Scientific Inc.
9.4. FUJIFILM Irvine Scientific
9.5. Nikon Instruments Inc.
9.6. Merck KGaA
9.7. Liverpool Partners (Genea Limited)
9.8. Hamilton Thorne, Inc. (IVFtech ApS)